Regeneron Pharmaceuticals Inc (OQ:REGN)

Business Focus: Bio Therapeutic Drugs

Latest 10 SEC filings (by transaction date) for REGN within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Mar 22/19 Mar 21/19 Schleifer Leonard S Direct Ownership Non-Qualified Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -100  
Mar 22/19 Mar 21/19 Schleifer Leonard S Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 100 $21.25
Mar 12/19 Mar 8/19 Sanofi Direct Ownership Common Stock S - Open market or private sale -131,115 $412.17
Jan 18/19 Jan 18/19 Fenimore Christopher R. Direct Ownership Incentive Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -150  
Jan 18/19 Jan 18/19 Fenimore Christopher R. Indirect Ownership Common Stock G - Gift 150  
Jan 18/19 Jan 18/19 Fenimore Christopher R. Direct Ownership Common Stock G - Gift -150  
Jan 18/19 Jan 18/19 Fenimore Christopher R. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 150 $21.25
Jan 11/19 Jan 10/19 Goldstein Joseph L Direct Ownership Non-Qualified Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -1,791  
Jan 11/19 Jan 10/19 Goldstein Joseph L Direct Ownership Common Stock S - Open market or private sale -1,791 $410.00
Jan 11/19 Jan 10/19 Goldstein Joseph L Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 1,791 $273.67
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Latest 10 SEC filings (by filing date) for REGN within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Mar 22/19 Mar 21/19 Schleifer Leonard S Direct Ownership Non-Qualified Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -100  
Mar 22/19 Mar 21/19 Schleifer Leonard S Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 100 $21.25
Mar 12/19 Mar 8/19 Sanofi Direct Ownership Common Stock S - Open market or private sale -131,115 $412.17
Jan 18/19 Jan 18/19 Fenimore Christopher R. Direct Ownership Incentive Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -150  
Jan 18/19 Jan 18/19 Fenimore Christopher R. Indirect Ownership Common Stock G - Gift 150  
Jan 18/19 Jan 18/19 Fenimore Christopher R. Direct Ownership Common Stock G - Gift -150  
Jan 18/19 Jan 18/19 Fenimore Christopher R. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 150 $21.25
Jan 11/19 Jan 10/19 Goldstein Joseph L Direct Ownership Non-Qualified Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -1,791  
Jan 11/19 Jan 10/19 Goldstein Joseph L Direct Ownership Common Stock S - Open market or private sale -1,791 $410.00
Jan 11/19 Jan 10/19 Goldstein Joseph L Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 1,791 $273.67
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. During our beta offer, get free access to company PDF reports.
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $REGN

StockTwits